Allegro MicroSystems enters the week after a clean earnings beat with a wall of upgraded price targets and a stock that has nearly doubled from its April lows — yet short sellers have barely flinched.
The most striking feature of the current setup is the gap between what analysts are doing and what shorts are doing. The Street moved decisively on Friday. UBS analyst Timothy Arcuri raised his target to $55 and maintained a Buy within the past 24 hours. Wells Fargo lifted its target sharply, from $48 to $56, keeping Overweight. Mizuho moved to $54 from $44, Needham to $55 from $45, and Barclays to $48 from $46. The mean price target now runs around $50 — close to but slightly above the current $48.95 close — which means the broad analyst community is roughly caught up with the stock's move. That the targets are racing higher is unambiguous; that most are now only modestly above the share price tells you the Street is still calibrating how far the recovery can run.
Short positioning is a less urgent story, but not a simple one. Short interest runs at 6.7% of the free float — meaningful, and it has grown about 10% over the past month even as the stock rallied 47%. That pattern points to shorts rebuilding into strength rather than covering. Days to cover from the FINRA reading is 7.5, which provides some cushion against rapid unwinds. Borrowing costs remain negligible at 0.52%, and the borrow market is effectively loose — only about a fifth of available shares have been lent out, well below the 52-week peak of 23.75%. There is nothing in the lending market to suggest a squeeze is imminent. If anything, the growing short base into a rising stock is a more interesting tension than the absolute level of SI.
Options tell a calmer story than the short side. The put/call ratio has dropped to 0.40, below its 20-day average of 0.44, and options positioning has drifted toward calls after what was a more hedged stance through late April, when the PCR ran in the 0.51–0.53 range. The shift coincides with the earnings catalyst passing and targets lifting — investors are apparently less focused on downside protection than they were two weeks ago.
The bull case, as articulated by the company and reflected in analyst commentary, centres on a fifth consecutive quarter of rising bookings, inventory drawdown across the channel, and early signs of component shortages that historically precede an up-cycle. EPS momentum is a standout on a 90-day basis, ranking in the 95th percentile of the universe, and forward EPS growth estimates are near the 92nd percentile. EV/EBITDA has compressed roughly 1.9x over the past month to 31.5x — the multiple is re-rating lower even as the price rallies, a sign that earnings estimates are moving faster than the stock. The bear case rests on margin pressure: gross margins have been squeezed by price concessions that have outpaced supplier cost reductions, and the product mix shift adds further drag. Whether the up-cycle narrative is strong enough to override those structural headwinds is the core debate.
Institutional ownership adds an important structural note. Parent company Sanken Electric holds 32% of shares, limiting the genuine free float. FMR (Fidelity) added nearly 3.8 million shares in Q1, bringing its stake to 14.8%. Invesco added almost 2 million shares. BlackRock added 824,000 in the most recent period. The buying pressure from large institutions during the April drawdown provides a natural bid that could explain why the stock recovered as sharply as it did.
The Q3 earnings print on May 7 has now passed with the stock falling 4.7% on the day, so the next formal catalyst is unscheduled. What to watch from here is whether the short base — which has grown 10% in a month — begins to unwind in earnest as the analyst consensus hardens, or whether it continues to grow as traders fade the magnitude of the April–May recovery.
See the live data behind this article on ORTEX.
Open ALGM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
